Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | PHAT | TECX | ||
| Company | Gracell Biotechnologies Inc ADR | Phathom Pharmaceuticals Inc | Tectonic Therapeutic Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 9.25 | 36.51 | ||
| High | 10.28 | 9.30 | 36.52 | ||
| Low | 10.17 | 8.79 | 35.68 | ||
| Last | 10.25 | 8.76 | 35.90 | ||
| Change | +0.01 | -0.56 | -1.14 | ||
| Percent Change | +0.05% | -6.01% | -3.08% | ||
| Volume | 6,417,100 | 146,499 | 29,511 | ||
| 20-Day Average Volume | 1,332,340 | 1,714,144 | 195,232 | ||
| Previous | 10.25 | 9.32 | 37.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 9.44 | 31.88 | ||
| 20-Day Raw Stochastic | 53.16% | 18.36% | 87.23% | ||
| 20-Day Relative Strength | 72.75 | 41.73 | 58.36 | ||
| Weighted Alpha | +228.20 | -30.70 | +42.01 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | -2.51% since 08/13/26 | +6.50% since 08/13/26 | ||
| Low | 10.09 on 02/16/24 | 8.95 on 08/20/26 | 33.32 on 08/14/26 | ||
| High | 10.35 on 02/14/24 | 9.74 on 08/18/26 | 37.50 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | -15.96% since 07/20/26 | +12.85% since 07/20/26 | ||
| Low | 9.97 on 01/22/24 | 8.21 on 08/05/26 | 27.24 on 07/31/26 | ||
| High | 10.44 on 02/09/24 | 12.24 on 07/28/26 | 37.50 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | -24.60% since 05/20/26 | +25.49% since 05/20/26 | ||
| Low | 3.80 on 11/28/23 | 8.21 on 08/05/26 | 27.00 on 06/03/26 | ||
| High | 10.44 on 02/09/24 | 12.64 on 07/13/26 | 39.53 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | -21.63% since 02/20/26 | +69.35% since 02/20/26 | ||
| Low | 2.10 on 10/04/23 | 8.21 on 08/05/26 | 20.95 on 02/25/26 | ||
| High | 10.44 on 02/09/24 | 14.39 on 02/26/26 | 39.53 on 07/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 753,997 | 724,095 | ||
| Shares Outstanding, K | 72,678 | 80,901 | 19,549 | ||
| Annual Sales, $M | 0 | 175,110,000 | 0 | ||
| Annual Net Income, $M | -88,080,000 | -221,250,000 | -74,150,000 | ||
| Last Qtr Sales, $M | 0 | 74,270,000 | 0 | ||
| Last Qtr Income, $M | -9,270,000 | -17,580,000 | -22,290,000 | ||
| 60-Month Beta | -0.33 | 0.51 | 3.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | 0.00 on 07/30/26 | -1.18 on 08/06/26 | ||
| Latest Earnings Date | 03/11/24 | 10/29/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||